Deltanoid Pharmaceuticals

About:

Deltanoid Pharmaceuticals Inc. is a privately funded biopharmaceutical company.

Website: http://deltanoid.com

Top Investors: Mason Wells, Venture Investors, Wisconsin Alumni Research Foundation

Description:

Deltanoid Pharmaceuticals Inc. is a privately funded biopharmaceutical company based in Madison, Wisconsin, engaged in research, development and commercialization of novel therapies for the treatment of human diseases. The company was founded to advance the development of raw university inventions, with an initial focus on vitamin D analogs and other compounds licensed from the Wisconsin Alumni Research Foundation. Deltanoid's continued focus is to develop selected therapies through early phases of the drug development process and seek partners for later stage development and commercialization in a wide variety of therapeutic areas, including renal disease, osteoporosis, and acne. Currently Deltanoid has a partnership agreement in place with Novadiol, Inc. for development of a vitamin D therapy.

Total Funding Amount:

$16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)deltanoid.com

Founders:

Hector F. DeLuca, Margaret Clagett-Dame

Number of Employees:

11-50

Last Funding Date:

2007-12-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai